What is the public reaction towards the news that a vaccine against cervical can

Worldwide, cervical cancer is the third most common type of cancer in women. So news that a vaccine is to be put on the market has been hailed as a major breakthrough. The drug Gadsill protects women against some strains of the virus HPV, which triggers cancer in a portion of the uterus. It’s been developed by the American pharmaceutical company Merk and it’s now been approved by the authorities for use within the US. The death rate from cervical cancer is falling in rich countries as it’s frequently detected at an early stage. However, it is still a major cause of death in the developing world.